

PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contract
You can purchase shares of PAVmed (NASDAQ:PAVM) through any online brokerage.
Other companies in PAVmed’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
PAVmed has a consensus price target of $57.00.
The stock price for PAVmed (NASDAQ: PAVM) is $1.53 last updated November 11, 2026 at 9:07 AM EST.
There are no upcoming dividends for PAVmed.
PAVmed does not have any upcoming earnings scheduled.
There is no upcoming split for PAVmed.
PAVmed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with...